VLRX

Valeritas (VLRX)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VLRX
DataOraFonteTitoloSimboloCompagnia
15/02/202000:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VLRXValeritas Holdings Inc
14/02/202016:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VLRXValeritas Holdings Inc
10/02/202002:21PR Newswire (US)Valeritas Announces Agreement for Zealand Pharma to Acquire Business and Retain EmployeesNASDAQ:VLRXValeritas Holdings Inc
23/01/202022:36Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VLRXValeritas Holdings Inc
23/12/201923:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VLRXValeritas Holdings Inc
20/12/201914:45GlobeNewswire Inc.Valeritas Experiences a Temporary Supply Disruption Resulting in Revised Preliminary Financial Results for 2019 Fourth Quarte...NASDAQ:VLRXValeritas Holdings Inc
09/12/201913:00GlobeNewswire Inc.Valeritas Presents Positive h-Patch™ CBD Study Data as a Late-Breaking Presentation at the American Epilepsy Society 2019 A...NASDAQ:VLRXValeritas Holdings Inc
15/11/201913:00GlobeNewswire Inc.Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Reductions in A1c and Daily Insulin UsageNASDAQ:VLRXValeritas Holdings Inc
12/11/201923:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VLRXValeritas Holdings Inc
12/11/201922:05GlobeNewswire Inc.Valeritas Announces Third Quarter 2019 Financial ResultsNASDAQ:VLRXValeritas Holdings Inc
29/10/201912:00GlobeNewswire Inc.Valeritas Presents Positive h-Patch™ Apomorphine Study Data at the World Congress of Neurology (WCN 2019)NASDAQ:VLRXValeritas Holdings Inc
24/10/201913:00GlobeNewswire Inc.Valeritas to Report Third Quarter 2019 Financial Results on November 12, 2019NASDAQ:VLRXValeritas Holdings Inc
21/10/201913:00GlobeNewswire Inc.GLP-1 Analogue Delivered Robustly via Subcutaneous Infusion with Valeritas Proprietary h-Patch™ Wearable Device in Preclin...NASDAQ:VLRXValeritas Holdings Inc
15/10/201913:00GlobeNewswire Inc.Valeritas Presents Positive h-Patch™ Apomorphine Study Data at Global Experts Meeting on Frontiers in Alzheimer’s Disease...NASDAQ:VLRXValeritas Holdings Inc
10/10/201913:00GlobeNewswire Inc.Valeritas Announces Poster Presentation of Preclinical h-Patch™ Cannabidiol (CBD) Study at the American Epilepsy Society's ...NASDAQ:VLRXValeritas Holdings Inc
08/10/201913:00GlobeNewswire Inc.Valeritas Announces Poster Presentation of Preclinical h-Patch™ Apomorphine Study at the World Congress of Neurology (WCN 2...NASDAQ:VLRXValeritas Holdings Inc
04/10/201922:13Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:VLRXValeritas Holdings Inc
03/10/201913:00GlobeNewswire Inc.Valeritas Hosts Educational Symposium and Participates in the Metabolic & Endocrine Disease Summit (MEDS) EastNASDAQ:VLRXValeritas Holdings Inc
02/10/201923:16Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:VLRXValeritas Holdings Inc
02/10/201913:00GlobeNewswire Inc.Valeritas Reduces its Long-Term Debt Obligation Nearly 60% by Exchanging $25.0 Million of Debt for Series B Convertible Prefe...NASDAQ:VLRXValeritas Holdings Inc
26/09/201915:31GlobeNewswire Inc.Valeritas Announces Participation on “The Cutting Edge of Cannabinoid Science” Panel at the CBD Expo EAST ConferenceNASDAQ:VLRXValeritas Holdings Inc
24/09/201913:00GlobeNewswire Inc.Valeritas Presents Positive h-Patch™ CBD Study Data at CannMed ConferenceNASDAQ:VLRXValeritas Holdings Inc
19/09/201913:00GlobeNewswire Inc.Valeritas Announces Presentation of Preclinical h-Patch™ CBD Study at CannMed ConferenceNASDAQ:VLRXValeritas Holdings Inc
17/09/201913:00GlobeNewswire Inc.Valeritas Announces Poster Presentation of Preclinical h-Patch™ Apomorphine Study at the Global Experts Meeting on Frontier...NASDAQ:VLRXValeritas Holdings Inc
12/09/201913:00GlobeNewswire Inc.Valeritas Presents Positive CBD h-Patch™ Data at the 2nd Annual International Cannabinoid-Derived Pharmaceuticals SummitNASDAQ:VLRXValeritas Holdings Inc
10/09/201912:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VLRXValeritas Holdings Inc
05/09/201922:07Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:VLRXValeritas Holdings Inc
03/09/201913:00GlobeNewswire Inc.Valeritas Announces Oral Presentation of Preclinical h-Patch™ CBD Study at the 2nd Annual International Cannabinoid-Derived...NASDAQ:VLRXValeritas Holdings Inc
29/08/201922:05GlobeNewswire Inc.Valeritas Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:VLRXValeritas Holdings Inc
15/08/201913:00GlobeNewswire Inc.Clinical Trial Evaluating Delivery of Regular Human Insulin vs. Rapid Acting Insulin Delivered by Valeritas’ V-Go® Meets P...NASDAQ:VLRXValeritas Holdings Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VLRX
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network